Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

RUFINA P MIEL

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1063470391
CMS profile
275605
Location
FOUNTAIN VALLEY, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$29,256.95

293 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Paying entityAmountRecords
AVYXA PHARMA, LLC $4,549.24 7
GENZYME CORPORATION $4,367.16 11
Janssen Biotech, Inc. $3,930.35 21
GlaxoSmithKline, LLC. $2,773.76 11
AstraZeneca Pharmaceuticals LP $2,733.93 16
PFIZER INC. $1,787.15 13
Novartis Pharmaceuticals Corporation $1,628.40 30
Genmab U.S., Inc. $1,575.00 1
Janssen Scientific Affairs, LLC $372.34 3
Novocure Inc. $342.99 5
E.R. Squibb & Sons, L.L.C. $332.27 14
Merck Sharp & Dohme LLC $314.29 11
SOBI, INC $307.07 11
ABBVIE INC. $266.84 4
Incyte Corporation $248.99 14
PharmaEssentia USA Corporation $229.07 5
SEAGEN INC. $199.98 2
Daiichi Sankyo Inc. $199.42 5
Eisai Inc. $186.08 8
Exelixis Inc. $167.23 5
Syndax Pharmaceuticals, Inc. $150.70 3
Caris MPI, Inc. $148.56 3
Sumitomo Pharma America, Inc. $137.90 5
Takeda Pharmaceuticals U.S.A., Inc. $137.19 5
ARRAY BIOPHARMA INC $129.95 7
Genentech USA, Inc. $128.40 5
Geron Corporation $120.99 1
Celgene Corporation $116.66 6
ADC THERAPEUTICS AMERICA, INC. $114.76 4
Stemline Therapeutics Inc. $110.12 4
Aveo Pharmaceuticals, Inc. $95.20 3
Dendreon Pharmaceuticals LLC $93.46 3
Deciphera Pharmaceuticals Inc. $85.28 2
Fennec Pharmaceuticals, Inc. $83.68 1
Karyopharm Therapeutics Inc. $80.97 3
RECORDATI_RARE_DISEASES_INC. $73.96 3
Lilly USA, LLC $71.58 3
Boehringer Ingelheim Pharmaceuticals, Inc. $67.61 2
Pharmacosmos Therapeutics Inc. $66.23 3
BeOne Medicines USA, Inc. $61.35 2
Agios Pharmaceuticals, Inc. $58.70 2
Gilead Sciences, Inc. $56.29 2
GE HEALTHCARE $55.06 2
Regeneron Healthcare Solutions, Inc. $47.50 1
Astellas Pharma US Inc $44.22 2
Coherus Oncology, Inc. $41.88 2
Iovance Biotherapeutics, Inc. $41.06 2
Boston Scientific Corporation $40.62 2
EMD Serono, Inc. $33.09 1
TAIHO ONCOLOGY, INC. $31.01 1
Invivyd Inc $26.61 1
Bayer Healthcare Pharmaceuticals Inc. $25.06 1
Azurity Pharmaceuticals, Inc. $22.58 1
TOLMAR, INC. $21.95 1
Adaptive Biotechnologies Corporation $20.11 1
Alexion Pharmaceuticals, Inc. $19.53 1
JAZZ PHARMACEUTICALS INC. $19.47 1
Cumberland Pharmaceuticals, Inc. $19.14 1
Ipsen Biopharmaceuticals, Inc $17.16 1
Rigel Pharmaceuticals, Inc. $15.10 1
SERVIER PHARMACEUTICALS LLC $14.70 1

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

293 matching records · $29,256.95 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 293 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 293.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Novartis Pharmaceuticals Corporation $83.3312/30/2025 Long term medical supply or device loan No dispute reported Delay: No
Change: NEW
06/30/20261200684585 CMS
Caris MPI, Inc. $134.9612/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261234283186 CMS
PFIZER INC. $118.8512/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261229404660 CMS
AstraZeneca Pharmaceuticals LP $119.7612/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261242510168 CMS
Novartis Pharmaceuticals Corporation $83.3311/26/2025 Long term medical supply or device loan No dispute reported Delay: No
Change: NEW
06/30/20261200684583 CMS
Genmab U.S., Inc. $1,575.0011/21/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261235926204 CMS
GlaxoSmithKline, LLC. $1,300.0011/20/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261190512292 CMS
Caris MPI, Inc. $6.1111/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261234283184 CMS
AVYXA PHARMA, LLC $2,000.0011/08/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/20261240100513 CMS
AVYXA PHARMA, LLC $175.3911/08/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261240100515 CMS
AVYXA PHARMA, LLC $177.1411/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261240100517 CMS
AVYXA PHARMA, LLC $681.7211/08/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261240100519 CMS
AVYXA PHARMA, LLC $1,247.9311/08/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261240100577 CMS
AVYXA PHARMA, LLC $89.9311/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261240100579 CMS
AVYXA PHARMA, LLC $177.1311/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261240100581 CMS
AstraZeneca Pharmaceuticals LP $91.8111/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261206602482 CMS
Janssen Biotech, Inc. $1,080.0011/03/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261174605880 CMS
GlaxoSmithKline, LLC. $10.2610/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261190378433 CMS
GlaxoSmithKline, LLC. $13.2110/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261190873429 CMS
AstraZeneca Pharmaceuticals LP $19.9710/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261206363851 CMS
Genentech USA, Inc. $21.5410/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261211579790 CMS
Janssen Biotech, Inc. $33.5110/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261174606064 CMS
PharmaEssentia USA Corporation $108.5910/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261246823171 CMS
PFIZER INC. $29.6810/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261229564261 CMS
E.R. Squibb & Sons, L.L.C. $24.2910/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261184583311 CMS
Sumitomo Pharma America, Inc. $8.1110/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261176692165 CMS
Incyte Corporation $25.8510/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261226185940 CMS
Novartis Pharmaceuticals Corporation $83.3310/23/2025 Long term medical supply or device loan No dispute reported Delay: No
Change: NEW
06/30/20261200684581 CMS
Novartis Pharmaceuticals Corporation $30.4210/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261200600573 CMS
PFIZER INC. $14.2710/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261229366861 CMS
GlaxoSmithKline, LLC. $21.1310/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261190827598 CMS
Dendreon Pharmaceuticals LLC $33.0310/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261245006648 CMS
AstraZeneca Pharmaceuticals LP $2,010.0010/10/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261206179614 CMS
AstraZeneca Pharmaceuticals LP $28.7210/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261206612886 CMS
Janssen Biotech, Inc. $19.0910/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261174602837 CMS
Merck Sharp & Dohme LLC $31.8210/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261238221872 CMS
Takeda Pharmaceuticals U.S.A., Inc. $33.4610/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261223931725 CMS
Eisai Inc. $20.2010/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261244509769 CMS
Novartis Pharmaceuticals Corporation $19.5010/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261200684579 CMS
GENZYME CORPORATION $39.4410/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261233341114 CMS
Novocure Inc. $24.4910/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261251152874 CMS
Coherus Oncology, Inc. $19.5309/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261235236697 CMS
Celgene Corporation $18.8709/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261184583297 CMS
PharmaEssentia USA Corporation $27.7109/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261246823121 CMS
E.R. Squibb & Sons, L.L.C. $18.6409/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261184583307 CMS
GENZYME CORPORATION $116.9209/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261233341098 CMS
GENZYME CORPORATION $3,912.0009/24/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/20261233341100 CMS
GENZYME CORPORATION $18.6209/24/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261233341102 CMS
Incyte Corporation $17.6909/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261226161333 CMS
Celgene Corporation $26.7109/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261184583287 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $3,946.49 175
PY2020 $14,073.21 188
PY2021 $6,900.58 224
PY2022 $7,037.78 253
PY2023 $13,445.95 275
PY2024 $27,880.94 342
PY2025 $29,256.95 293

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
RUFINA P MIEL, NPI 1063470391. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1063470391.
APA 7
IndustryPayments. (2026). RUFINA P MIEL, NPI 1063470391 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1063470391
Bluebook
RUFINA P MIEL, NPI 1063470391, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1063470391.

Source: Centers for Medicare & Medicaid Services, Open Payments.